Bristol-Myers Squibb Pharmaceuticals Ltd
- C01 - Terapia cardíaca
- PRONESTYL solution for injection 1 g/10 ml
- C10 - Agentes modificadores de los lípidos
- QUESTRAN powder for oral suspension 4 g
- H02 - Corticosteroides para uso sistémico
- ADCORTYL suspension for injection 10 mg/ml
- KENALOG suspension for injection 40 mg/1 ml
- J01 - Antibacterianos para uso sistémico
- AZACTAM powder for solution for injection 1 g
- AZACTAM powder for solution for injection 2 g
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- BARACLUDE oral solution 0.05 mg/ml
- EVOTAZ film-coated tablet 300 mg+150 mg
- SUSTIVA capsule, hard 100 mg
- SUSTIVA capsule, hard 200 mg
- SUSTIVA capsule, hard 50 mg
- SUSTIVA film-coated tablet 600 mg
- L01 - Antineoplásicos
- ABECMA dispersion 260 to 500 M.cells
- EMPLICITI lyophilisate for solution for infusion 300 mg
- EMPLICITI lyophilisate for solution for infusion 400 mg
- HYDREA capsule, hard 500 mg
- OPDIVO concentrate for solution for infusion 10 mg/ml
- SPRYCEL powder for oral suspension 10 mg/ml
- YERVOY concentrate for solution for infusion 5 mg/ml
- L04 - Inmunosupresores
- NULOJIX concentrate for solution for infusion 250 mg
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED PEN solution for injection 125 mg/1 ml
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/1 ml
- ORENCIA PREFILLED SYRINGE solution for injection 50 mg/0.4 ml
- ORENCIA PREFILLED SYRINGE solution for injection 87.5 mg/0.7 ml
- N02 - Analgésicos
- PERFALGAN solution for infusion 1 g/100 ml
- PERFALGAN solution for infusion 500 mg/50 ml
- N05 - Psicolépticos
- ABILIFY orodispersible tablet 30 mg